ORPHA:398063
Refractory celiac disease
Also known as: Refractory CD · Refractory sprue
Publications
2,279
Trials
1
Interventional, condition-specific
Researchers
1,263
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Refractory celiac disease is a rare intestinal disease characterized by persistent or recurrent symptoms and signs of confirmed celiac disease despite a long-term, strict, gluten-free diet, in the absence of other causes of villous atrophy or malignant complications and with or without presence of increased abnormal intraepitelial lymphocytes.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018353
- UMLS:C4749333
Additional Mondo synonyms (4)
intractable celiac sprue · intractable coeliac sprue · refractory CD · refractory sprue
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
2,279 matched papers (1,428 in last 10 years) Source
- Phenotype characterisedPresent
29 HPO annotations (e.g. Microcytic anemia; Osteoporosis; Hypocalcemia) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
1 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
29
Associated phenotypes · MONDO:0018353
- Microcytic anemia
- Osteoporosis
- Hypocalcemia
- Hypophosphatemia
- Jejunitis
Showing 5 of 29 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
2,279
2,279 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
2,279 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,428 in the last 10 years · low confidence
Phrase hits: 2,279 · MeSH hits: 0
Who's working on it?
1,263
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Elli L10 papers · 2025
Centre for Prevention and Diagnosis of Coeliac Disease, Gastroenterology and Endoscopy Unit, Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Italy (Luca Elli, Lucia Scaramella, Gian Eugenio Tontini).
Papers in Europe PMC - 02Bouma G6 papers · 2026
Department of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, AGEM Institute, Amsterdam, the Netherlands.
Papers in Europe PMC - 03Nandi N6 papers · 2025
Academic Unit of Gastroenterology, Sheffield Teaching Hospitals National Health Service Foundation Trust, Sheffield; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom. nicoletta.nandi@unimi.it.
Papers in Europe PMC - 04Ciccocioppo R5 papers · 2025
Gastroenterology Unit, Department of Medicine, A.O.U.I. Borgo Roma and University of Verona, 37134 Verona, Italy.
Papers in Europe PMC - 05Li J5 papers · 2025
Department of Pathology, Tongji Hospital Affiliated to Tongji University School of Medicine, Shanghai 200065, China.
Papers in Europe PMC - 06Vecchi M5 papers · 2023
Division of Gastroenterology and Endoscopy, Center for Prevention and Diagnosis of Celiac Disease, Foundation IRCCS Ca' Granda Major Polyclinic Hospital, Milan, Italy.
Papers in Europe PMC - 07Bontkes HJ4 papers · 2026
Laboratory Medical Immunology, Department of Clinical Chemistry, Amsterdam UMC, AGEM Research Institute, AI & I Institute, Amsterdam, the Netherlands.
Papers in Europe PMC - 08Branchi F4 papers · 2022
Division of Gastroenterology and Endoscopy, Center for Prevention and Diagnosis of Celiac Disease, Foundation IRCCS Ca' Granda Major Polyclinic Hospital, Milan, Italy.
Papers in Europe PMC - 09Koning F4 papers · 2026
Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Papers in Europe PMC - 10Sanders DS4 papers · 2025
Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
1
interventional trials for this specific condition
1 interventional trial matched this specific condition name; none in our sample are currently recruiting.
Data as of 11 September 2026
1 interventional trial — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 80.1th percentile).
low confidence · 80.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
1 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07556328·RECRUITING·Histomolecular Profiling in Small-Bowel Diseases
Not reviewed·Conditions: Celiac Disease · Small Bowel Disease · Refractory Celiac Disease·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 14 · after dedupe 14 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 14 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (14)
- ctis·2024-520125-36-00·Authorised, recruiting·A Phase 1b Study of the Safety and Pharmacokinetics of Pivekimab Sunirine in Pediatric Subjects with Relapsed or Refractory Acute Myeloid Leukemia (AML).
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN79155276·No longer recruiting·A study to learn if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10142971·Recruiting·A trial to find a safe dose of drug treatment combined with radiotherapy for non small cell lung cancer (CONCORDE)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15038320·Recruiting·A phase 1b/2 study of JNJ-90014496 in Adult Participants with B-Cell non-Hodgkin lymphoma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17666983·No longer recruiting·A Study of JNJ-90009530 in Relapsed or Refractory B-Cell non-Hodgkin Lymphoma (r/r B-NHL)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66696088·Recruiting·Treatment of reflux disease using targeted physiotherapy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13185938·No longer recruiting·A study of JNJ-79635322 in participants with relapsed or refractory multiple myeloma or previously treated amyloid light-chain (AL) amyloidosis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN80103507·No longer recruiting·A clinical trial to see if a mesenchymal stem cells treatment called ORBCEL-C™ can help to treat primary sclerosing cholangitis, rheumatoid arthritis, lupus nephritis and Crohn’s disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17160440·No longer recruiting·A randomised controlled trial to assess the safety and effectiveness of stem cell transplantation using a reduced intensity regimen in patients with treatment resistant Crohn’s disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN58227268·No longer recruiting·Cyclophosphamide and dexamethasone in combination with Ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenolidomide and bortezomib
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36210045·No longer recruiting·Radioimmunotherapy with 90Y Ibritumumab Tiuxetan in B-cell CD20+ indolent non-Hodgkin Lymphoma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN49387307·No longer recruiting·Shortness Of Breath in Lung Cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN64619216·No longer recruiting·A pilot, open-label, multicentre study to investigate the safety of calf intestine alkaline phosphatase in patients with fulminant active ulcerative colitis refractory to steroid therapy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN61510219·No longer recruiting·The ideal management of Crohn's disease: top-down versus step-up strategies - a prospective controlled trial in the Benelux
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Refractory celiac disease — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Refractory celiac disease" OR "Refractory CD" OR "Refractory sprue" OR "intractable celiac sprue" OR "intractable coeliac sprue"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Refractory celiac disease" OR "Refractory CD" OR "Refractory sprue" OR "intractable celiac sprue" OR "intractable coeliac sprue"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 1 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (2279) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T15:16:59.973Z
